Coronavirus Pandemic: Alarming 60% decline in crucial prostate cancer testing
The CEO of Prostate Cancer Foundation of Australia (PCFA) shines a spotlight on a worrying prostate cancer trend in light of the current COVID-19 threat and restrictions in Australia. Prof Jeff Dunn reports there has been a 60% reduction in important prostate cancer testing over March to April 2020, and he warns of a potential ‘tidal wave’ of diagnoses in 12 months time as a result.
Tag: ABC News, Active Surveillance, Australia, Coronavirus;, COVID-19, Jeff Dunn, Localised, Low-Risk, Men, Navigate, PCFA, Prostate Cancer, PSA
